1489 Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Accelerate Growth of VK2 Vaginal Epithelial Cells Through Micrornas in Vitro

Z Zhu,L Wu,J Ding,K Hua

DOI: https://doi.org/10.1016/j.jmig.2019.09.285

IF: 4.314

2019-01-01

Journal of Minimally Invasive Gynecology

Abstract:Study Objective To investigate whether and how human umbilical cord mesenchymal stem cell-derived exosomes (hucMSC-Ex) could accelerate vaginal epithelium cell (VK2) growth. Design hucMSC and exosomes isolated from their conditioned medium were used to treat VK2. Setting Normal human fibroblasts (HFF-1) were used as negative control to hucMSC. Patients or Participants N/A Interventions VK2 cells were co-cultured with hucMSC whose paracrine effect on the viability, cell cycle and cell apoptosis of VK2 vaginal epithelial cells was further assessed by CCK-8 assay and flowcytometry. After identified by TEM-NTA-WB, hucMSC-Ex at different concentrations were used to treat VK2. High-throughput RNA sequencing was utilized to reveal the profile of microRNAs in hucMSC, HFF-1 and their exosomes. The functions of hucMSC-Ex specific microRNAs in VK2 were demonstrated by GeneOntology analysis and confirmed by phenotypic detection in microRNA mimics and inhibitors transfected VK2 and RNAi-hucMSC-Ex treated VK2 cells. Measurements and Main Results hucMSC stimulate VK2 growth through a paracrine route by promoting cell cycle and inhibiting apoptosis. Compared with control and low dose groups, hucMSC-Ex of high concentration (≥1000 ng/ml) significantly increased VK2’s growth after treatment in a dose-depended manner (P < 0.05). HucMSC-Ex raised the proportion of cells in S-phase and reduced the percentage of apoptotic cells in VK2. microRNAs, including miR-100 (16.92%), miR-146a (9.21%), miR-21 (6.67%), miR-221 (6.39%) and miR-143 (4.63%), were found to be specifically enriched (P < 0.05) in hucMSC-Ex and their functions concentrated on cell cycle, development and differentiation. Conclusion Our findings indicate that hucMSC-Ex may play a significant role in accelerating VK2’s proliferation by promoting cell cycle and inhibiting apoptosis through exosomal microRNAs in vitro. This supports the potential use of hucMSC-Ex as a cell-free therapy of MRKHS after vaginoplasty. This study was supported by Chinese National Nature Sciences Foundation (grant number 91440107, 81471416 and 81771524) and Strategic Priority Research Program of the Chinese Academy of Sciences (XDB19040102). To investigate whether and how human umbilical cord mesenchymal stem cell-derived exosomes (hucMSC-Ex) could accelerate vaginal epithelium cell (VK2) growth. hucMSC and exosomes isolated from their conditioned medium were used to treat VK2. Normal human fibroblasts (HFF-1) were used as negative control to hucMSC. N/A VK2 cells were co-cultured with hucMSC whose paracrine effect on the viability, cell cycle and cell apoptosis of VK2 vaginal epithelial cells was further assessed by CCK-8 assay and flowcytometry. After identified by TEM-NTA-WB, hucMSC-Ex at different concentrations were used to treat VK2. High-throughput RNA sequencing was utilized to reveal the profile of microRNAs in hucMSC, HFF-1 and their exosomes. The functions of hucMSC-Ex specific microRNAs in VK2 were demonstrated by GeneOntology analysis and confirmed by phenotypic detection in microRNA mimics and inhibitors transfected VK2 and RNAi-hucMSC-Ex treated VK2 cells. hucMSC stimulate VK2 growth through a paracrine route by promoting cell cycle and inhibiting apoptosis. Compared with control and low dose groups, hucMSC-Ex of high concentration (≥1000 ng/ml) significantly increased VK2’s growth after treatment in a dose-depended manner (P < 0.05). HucMSC-Ex raised the proportion of cells in S-phase and reduced the percentage of apoptotic cells in VK2. microRNAs, including miR-100 (16.92%), miR-146a (9.21%), miR-21 (6.67%), miR-221 (6.39%) and miR-143 (4.63%), were found to be specifically enriched (P < 0.05) in hucMSC-Ex and their functions concentrated on cell cycle, development and differentiation. Our findings indicate that hucMSC-Ex may play a significant role in accelerating VK2’s proliferation by promoting cell cycle and inhibiting apoptosis through exosomal microRNAs in vitro. This supports the potential use of hucMSC-Ex as a cell-free therapy of MRKHS after vaginoplasty. This study was supported by Chinese National Nature Sciences Foundation (grant number 91440107, 81471416 and 81771524) and Strategic Priority Research Program of the Chinese Academy of Sciences (XDB19040102).